Literature DB >> 22168437

Multiple roles for the p85α isoform in the regulation and function of PI3K signalling and receptor trafficking.

Paul Mellor1, Levi A Furber, Jennifer N K Nyarko, Deborah H Anderson.   

Abstract

The p85α protein is best known as the regulatory subunit of class 1A PI3Ks (phosphoinositide 3-kinases) through its interaction, stabilization and repression of p110-PI3K catalytic subunits. PI3Ks play multiple roles in the regulation of cell survival, signalling, proliferation, migration and vesicle trafficking. The present review will focus on p85α, with special emphasis on its important roles in the regulation of PTEN (phosphatase and tensin homologue deleted on chromosome 10) and Rab5 functions. The phosphatidylinositol-3-phosphatase PTEN directly counteracts PI3K signalling through dephosphorylation of PI3K lipid products. Thus the balance of p85α-p110 and p85α-PTEN complexes determines the signalling output of the PI3K/PTEN pathway, and under conditions of reduced p85α levels, the p85α-PTEN complex is selectively reduced, promoting PI3K signalling. Rab5 GTPases are important during the endocytosis, intracellular trafficking and degradation of activated receptor complexes. The p85α protein helps switch off Rab5, and if defective in this p85α function, results in sustained activated receptor tyrosine kinase signalling and cell transformation through disrupted receptor trafficking. The central role for p85α in the regulation of PTEN and Rab5 has widened the scope of p85α functions to include integration of PI3K activation (p110-mediated), deactivation (PTEN-mediated) and receptor trafficking/signalling (Rab5-mediated) functions, all with key roles in maintaining cellular homoeostasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22168437     DOI: 10.1042/BJ20111164

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

Review 1.  Thyroid hormone receptors and cancer.

Authors:  Won Gu Kim; Sheue-yann Cheng
Journal:  Biochim Biophys Acta       Date:  2012-04-06

2.  SUMOylation modulates the stability and function of PI3K-p110β.

Authors:  Ahmed El Motiam; Carlos F de la Cruz-Herrera; Santiago Vidal; Rocío Seoane; Maite Baz-Martínez; Yanis H Bouzaher; Emilio Lecona; Mariano Esteban; Manuel S Rodríguez; Anxo Vidal; Manuel Collado; Carmen Rivas
Journal:  Cell Mol Life Sci       Date:  2021-04-08       Impact factor: 9.261

3.  Folic Acid Protects Against Glutamate-Induced Excitotoxicity in Hippocampal Slices Through a Mechanism that Implicates Inhibition of GSK-3β and iNOS.

Authors:  Josiane Budni; Simone Molz; Tharine Dal-Cim; Maria Dolores Martín-de-Saavedra; Javier Egea; Manuela G Lopéz; Carla Ines Tasca; Ana Lúcia Severo Rodrigues
Journal:  Mol Neurobiol       Date:  2017-02-10       Impact factor: 5.590

4.  Sodium and potassium regulate endothelial phospholipase C-γ and Bmx.

Authors:  Wei-Zhong Ying; Kristal J Aaron; Paul W Sanders
Journal:  Am J Physiol Renal Physiol       Date:  2014-04-30

Review 5.  PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting.

Authors:  Lauren M Thorpe; Haluk Yuzugullu; Jean J Zhao
Journal:  Nat Rev Cancer       Date:  2015-01       Impact factor: 60.716

Review 6.  Duvelisib: a phosphoinositide-3 kinase δ/γ inhibitor for chronic lymphocytic leukemia.

Authors:  Hima V Vangapandu; Nitin Jain; Varsha Gandhi
Journal:  Expert Opin Investig Drugs       Date:  2017-04-13       Impact factor: 6.206

7.  Transforming growth factor-β regulates endothelial function during high salt intake in rats.

Authors:  Wei-Zhong Ying; Kristal J Aaron; Paul W Sanders
Journal:  Hypertension       Date:  2013-09-16       Impact factor: 10.190

Review 8.  Caspase-8 as a regulator of tumor cell motility.

Authors:  R P Graf; N Keller; S Barbero; D Stupack
Journal:  Curr Mol Med       Date:  2014-02       Impact factor: 2.222

9.  Synergistic Targeting of the Regulatory and Catalytic Subunits of PI3Kδ in Mature B-cell Malignancies.

Authors:  Jeffrey D Cooney; An-Ping Lin; Daifeng Jiang; Long Wang; Avvaru N Suhasini; Jamie Myers; ZhiJun Qiu; Albert Wölfler; Heinz Sill; Ricardo C T Aguiar
Journal:  Clin Cancer Res       Date:  2017-12-15       Impact factor: 12.531

10.  Loss-of-function RNAi screens in breast cancer cells identify AURKB, PLK1, PIK3R1, MAPK12, PRKD2, and PTK6 as sensitizing targets of rapamycin activity.

Authors:  Oliver Ou; Konrad Huppi; Sirisha Chakka; Kristen Gehlhaus; Wendy Dubois; Jyoti Patel; Jinqiu Chen; Mark Mackiewicz; Tamara L Jones; Jason J Pitt; Scott E Martin; Paul Goldsmith; John K Simmons; Beverly A Mock; Natasha J Caplen
Journal:  Cancer Lett       Date:  2014-09-01       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.